CareDx, Inc. (CDNA) income statement
CDNANasdaqServices-Medical LaboratoriesFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 12/3026% above fair value
$74.44−0.12 (-0.16%)
Close on Nov 18, 2026Market cap $3.91BP/E 31.1Yield –
CareDx, Inc. income statement
Ratios
Latest available, balances at Sep 30, 2026
Profitability, TTM
- Gross margin
- –
- Operating margin
- 23.4%
- Net margin
- 25.9%
- Return on equity, FY2025
- -6.3%
Financial strength
- Current ratio
- 2.31
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 180.2%
Valuation
- P/E ratio
- 31.1
- Price to sales
- 7.86
- Price to book
- 8.37
- Dividend yield
- –
See a number that looks wrong?